0.00Open7.95Pre Close0 Volume14 Open Interest17.50Strike Price0.00Turnover332.40%IV1.24%PremiumJan 10, 2025Expiry Date7.83Intrinsic Value100Multiplier2DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.9905Delta0.0121Gamma1.22Leverage Ratio-0.0050Theta-0.0005Rho-1.21Eff Leverage0.0002Vega
Novavax Stock Discussion
will move today once volume up
CVAX soared as much as 21.8% to a $4.41 session peak, while NVAX rose to as high as $10.03, up 13.3% on the day.
The stocks popped after the CDC said in its weekly national summary Friday that U.S. cases ...
$ScanTech AI Systems (STAI.US)$
$CNS Pharmaceuticals (CNSP.US)$
$Colombier Acquisition Corp II (CLBR.US)$
$Aditxt (ADTX.US)$
$E-Home Household Service (EJH.US)$
$Guardforce AI (GFAI.US)$
$GeoVax Labs (GOVX.US)$...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, some stocks may get pumped WITHOUT any catal...
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. It’s 2025, those newbies need to read and educate themselves on stocks. ...
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Novavax continues to progress Sanofi agreement by achieving first milestone, with additional milestones and ongoing tiered royalties to come, solidifying a strong model for future partnershipsNovavax's COVID-19 vaccine included in Sanofi's two combination vaccine candidates for prevention of influenza and COVID-19, for which Phase 1/2 trials were init...
No comment yet